Workflow
氟制冷剂(R22
icon
Search documents
三美股份(603379):制冷剂价格持续上涨,公司充分受益高景气周期
Capital Securities· 2025-10-30 07:15
Investment Rating - The investment rating for the company is "Buy" [1] Core Views - The company is benefiting from the continuous rise in refrigerant prices, which has led to significant performance improvements during a high prosperity cycle [2][5] - The company reported a revenue of 44.29 billion yuan for the first three quarters of 2025, representing a year-on-year increase of 45.72%, and a net profit of 15.91 billion yuan, up 183.66% year-on-year [6] - The company is expected to continue benefiting from the long-term prosperity cycle of refrigerants, with a projected net profit of 20.49 billion yuan in 2025, 24.60 billion yuan in 2026, and 28.93 billion yuan in 2027 [6][7] Financial Performance Summary - Revenue projections for the company are as follows: 40.40 billion yuan in 2024, 61.35 billion yuan in 2025, 67.31 billion yuan in 2026, and 74.59 billion yuan in 2027, with corresponding year-on-year growth rates of 21.2%, 51.9%, 9.7%, and 10.8% [3][7] - The company's net profit is projected to grow significantly, with estimates of 7.79 billion yuan in 2024, 20.49 billion yuan in 2025, 24.60 billion yuan in 2026, and 28.93 billion yuan in 2027, reflecting year-on-year growth rates of 178.4%, 163.3%, 20.0%, and 17.6% respectively [3][7] - The company's earnings per share (EPS) are expected to be 1.28 yuan in 2024, 3.36 yuan in 2025, 4.03 yuan in 2026, and 4.74 yuan in 2027, with corresponding price-to-earnings (PE) ratios of 45, 17, 14, and 12 [3][7] Market Dynamics - The company has seen a significant increase in the average selling price of refrigerants, with prices for R32, R134a, and R125 rising by 59.99%, 59.09%, and 46.06% year-on-year respectively in the third quarter of 2025 [6] - The company holds substantial production quotas for various refrigerants, positioning it well to benefit from the industry's recovery and growth [6]